NCT01097616 Safety and Efficacy Study of Suvorexant in Participants With Primary Insomnia - Study A (MK-4305-028) Status COMPLETED Phase PHASE3
NCT01096667 Study of Safety and Efficacy Of Ertugliflozin (PF-04971729, MK-8835) In Participants With Type 2 Diabetes And Hypertension (MK-8835-042) Status COMPLETED Phase PHASE2
NCT01096160 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK8266 in Hypertensive Men (MK-8266-002) Status COMPLETED Phase PHASE1
NCT01096134 Mother - Daughter Initiative (MDI) in Cervical Cancer Prevention Status COMPLETED Phase NA
NCT01093794 Bioequivalence Study of Sitagliptin/Metformin Combination Tablet (MK0431A-122) Status COMPLETED Phase PHASE1
NCT01092780 Pharmacodynamics and Efficacy of MK-7288 in Adults With Sleep Apnea (MK-7288-010) Status COMPLETED Phase PHASE1
NCT01089647 Montelukast and Inhaled Nasal Steroid Tx in Adult Obstructive Sleep Apnea (OSA) Status COMPLETED Phase PHASE3
NCT01088711 Evaluation of Omarigliptin (MK-3102) in Obese Participants and in Participants With Type 2 Diabetes (MK-3102-004) Status COMPLETED Phase PHASE1
NCT01087840 Raltegravir Use as Nonoccupational Postexposure Prophylaxis (NPEP) in Men Who Have Sex With Men Status COMPLETED Phase PHASE4
NCT01087164 Brief Interventions to Increase HPV Vaccine Acceptance in School-based Health Centers Status UNKNOWN Phase NA
NCT01087073 Improving Diabetes Care and Outcomes on the South Side of Chicago Status COMPLETED Phase NA
NCT01085916 Prevalence of Asthma and Rhinitis Symptoms Among Secondary School Students in Saudi Arabia Status UNKNOWN Phase N/A
NCT01081158 Safety, Tolerability, PK and PD of SCH 900518 in Naive or Treatment-Experienced Subjects Infected With HCV Genotype 1 (Protocol No. P04695) Status COMPLETED Phase PHASE1
NCT01078246 Post-Licensure Safety Study of ISENTRESS™ (Raltegravir) in a United States Managed Care Network (MK-0518-268) Status COMPLETED Phase N/A
NCT01078220 Observational Surveillance Study to Detect Potential Safety Signals in Patients Who Have Had at Least One Dose of GARDASIL™ (V501-031) Status COMPLETED Phase N/A
NCT01077804 A Study to Evaluate Long-term Impact of VARIVAX Among Children and Adolescents (V210-036)(COMPLETED) Status COMPLETED Phase N/A
NCT01077336 Clinical Outcomes in Candidemia Patients Based on in Vitro Susceptibility Status COMPLETED Phase N/A